Literature DB >> 29935424

Human papillomavirus 16 E6 modulates the expression of miR-496 in oropharyngeal cancer.

Dayna Sais1, Xiaoying Zhang2, Tânia Monteiro Marques3, Barbara Rose2, Samantha Khoury1, Meredith Hill1, Fiona Deutsch1, J Guy Lyons4, Margarida Gama-Carvalho3, Nham Tran5.   

Abstract

Human papillomavirus (HPV), notably type 16, is a risk factor for up to 75% of oropharyngeal squamous cell carcinomas (SCC). It has been demonstrated that small non-coding RNAs known as microRNAs play a vital role in the cellular transformation process. In this study, we used an LNA array to further investigate the impact of HPV16 on the expression of microRNAs in oropharyngeal (tonsillar) cancer. A number of miRNAs were found to be deregulated, with miR-496 showing a four-fold decrease. Over-expression of the high risk E6 oncoprotein down-regulated miR-496, impacting upon the post-transcriptional control of the transcription factor E2F2. These HPV specific miRNAs were integrated with the HPV16 interactome to identify possible mechanistic pathways. These analyses provide insights into novel molecular interactions between HPV16 and miRNAs in oropharyngeal cancers.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29935424     DOI: 10.1016/j.virol.2018.05.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.513


  3 in total

1.  MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF in osteosarcoma.

Authors:  Jing Ye; Wei Xie; Yunzhou Zuo; Guangwu Jing; Jie Tong
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447

2.  The Circular RNA circRNA124534 Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells Through Modulation of the miR-496/β-Catenin Pathway.

Authors:  Fang Ji; Jing Pan; Zhecheng Shen; Zhao Yang; Jian Wang; Xuebing Bai; Jiang Tao
Journal:  Front Cell Dev Biol       Date:  2020-04-03

3.  Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancer.

Authors:  Linda Hofmann; Tsima Abou Kors; Jasmin Ezić; Beate Niesler; Ralph Röth; Sonja Ludwig; Simon Laban; Patrick J Schuler; Thomas K Hoffmann; Cornelia Brunner; Valentin Medyany; Marie-Nicole Theodoraki
Journal:  Front Cell Dev Biol       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.